https://pubmed.ncbi.nlm.nih.gov/17054152/
Palliative radiotherapy regimens for non-small cell lung cancer
The majority of patients should be treated with short courses of palliative radiotherapy, of 1 or 2 fractions. Care should be taken with the dose to the spinal...
palliative radiotherapysmall cellregimensnonlung
https://pubmed.ncbi.nlm.nih.gov/30943739/?dopt=Abstract
Palliative radiotherapy: history, recent advances, and future directions
Radiotherapy has been used to palliate cancer symptoms since shortly after the time that X rays were discovered late in the 1800's. The 20th century witnessed...
palliative radiotherapyrecent advanceshistoryfuturedirections
https://cir.nii.ac.jp/crid/1360869854342796416?lang=ja
Hemostatic palliative radiotherapy for gastric cancer: A literature review | CiNii Research
palliative radiotherapygastric cancerliterature reviewhemostatic
https://pubmed.ncbi.nlm.nih.gov/25022254/?dopt=Abstract
Impact of comorbidity on survival after palliative radiotherapy
We recommend assessment of comorbidity when prescribing PRT and selecting the optimal fractionation regimen, because most patients with severe comorbidities...
on survivalimpactcomorbiditypalliativeradiotherapy
https://pubmed.ncbi.nlm.nih.gov/19362788/?dopt=Abstract
Estimating need for palliative external beam radiotherapy in adult cancer patients
The need for palliative radiotherapy has not decreased and might be greater than previously estimated. In regions with a significantly different cancer...
external beam radiotherapyneed forestimatingpalliative
https://pubmed.ncbi.nlm.nih.gov/22130630/?dopt=Abstract
Update on the systematic review of palliative radiotherapy trials for bone metastases
Overall and complete response rates were similar in both intention-to-treat and assessable patients. Single and multiple fraction regimens provided equal pain...
on thesystematic review
https://pubmed.ncbi.nlm.nih.gov/33287897/
Unexpected tumor response to palliative pelvic radiotherapy in mismatch repair-deficient advanced...
Routine evaluation of MSI in patients with locally problematic advanced tumors might change treatment strategy and treatment aim in this setting, from a purely...